Indomethacin-induced small intestinal injury is ameliorated by cilostazol, a specific PDE-3 inhibitor

Abstract

Our results suggest that enhanced platelets-bearing neutrophil migration is critically involved in the pathogenesis of IND-induced small intestinal lesions and suggest a potential application of cilostazol for prevention of NSAID-induced small intestinal lesions.